The most practice-changing, promising, and watchlist data — distilled into 3 bullets each.
Oct 23, 2025
ESMO 2025 brings a strong thoracic-oncology program, spanning peri-operative immunotherapy, next-generation ADCs, and long-term targeted-therapy follow-up. Below are ten key abstracts to keep on your radar.
Oct 16, 2025
